Supplemental material
Drug Delivery
Volume 24, 2017 - Issue 1
Open access
6,393
Views
67
CrossRef citations to date
0
Altmetric
Research Article
Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
Sandhya Pranatharthiharan1 Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (Deemed University, Elite Status), Mumbai, Maharashtra, India and
, Mitesh D. Patel1 Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (Deemed University, Elite Status), Mumbai, Maharashtra, India and
, Vinod C. Malshe1 Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (Deemed University, Elite Status), Mumbai, Maharashtra, India and
, Vaishali Pujari2 National Institute of Immunohaematology, Mumbai, Maharashtra, India
, Ajit Gorakshakar2 National Institute of Immunohaematology, Mumbai, Maharashtra, India
, Manisha Madkaikar2 National Institute of Immunohaematology, Mumbai, Maharashtra, India
, Kanjaksha Ghosh2 National Institute of Immunohaematology, Mumbai, Maharashtra, India
& Padma V. Devarajan1 Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (Deemed University, Elite Status), Mumbai, Maharashtra, India and Correspondence[email protected]; [email protected]
show all
Pages 20-29
|
Received 24 Jul 2016, Accepted 15 Aug 2016, Published online: 03 Feb 2017
Related Research Data
Specific capture of glycosylated graphene oxide by an asialoglycoprotein receptor: a strategic approach for liver-targeting
Source:
Royal Society of Chemistry (RSC)
Investigation of the transport and absorption of Angelica sinensis polysaccharide through gastrointestinal tract both in vitro and in vivo
Source:
Informa UK Limited
Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
Source:
Elsevier BV
Cellular disposition of arabinogalactan in primary cultured rat hepatocytes
Source:
Elsevier BV
Bioenhanced oral curcumin nanoparticles: Role of carbohydrates.
Source:
Elsevier BV
Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis
Source:
Springer Science and Business Media LLC
Diagnosis of hepatocellular carcinoma
Source:
International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd.
Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.
Source:
Elsevier BV
Fit-for purpose use of mouse models to improve predictivity of cancer therapeutics evaluation.
Source:
Elsevier BV
Lipoproteins tethered dendrimeric nanoconstructs for effective targeting to cancer cells
Source:
Springer Science and Business Media LLC
Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy.
Source:
Elsevier BV
Larch arabinogalactan for hepatic drug delivery: isolation and characterization of a 9 kDa arabinogalactan fragment.
Source:
Elsevier BV
Effect of integrin receptor‑targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy
Source:
Spandidos Publications
Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles.
Source:
Springer Science and Business Media LLC
Pharmacokinetics, biodistribution and receptor mediated endocytosis of a natural Angelica sinensis polysaccharide.
Source:
Informa UK Limited
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
Source:
Elsevier BV
Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1.
Source:
Proceedings of the National Academy of Sciences
Nanoparticles of Polyethylene Sebacate: A New Biodegradable Polymer
Source:
Springer Science and Business Media LLC
Retinoic acid decorated albumin-chitosan nanoparticles for targeted delivery of doxorubicin hydrochloride in hepatocellular carcinoma
Source:
Hindawi Publishing Corporation
pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma
Source:
Elsevier BV
Drug delivery: Beyond active tumour targeting
Source:
Elsevier BV
Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development
Source:
Bentham Science Publishers Ltd.
Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure
Source:
Elsevier BV
Current knowledge on biosynthesis, biological activity, and chemical modification of the exopolysaccharide, pullulan.
Source:
Elsevier BV
Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
Source:
Taylor & Francis
Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation
Source:
The University of North Carolina at Chapel Hill University Libraries
Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand
Source:
Springer Science and Business Media LLC
Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon
Source:
American Society for Microbiology
Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake.
Source:
Informa UK Limited
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
Source:
Elsevier BV
Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease
Source:
American Association for Cancer Research (AACR)
Mono-guanidine heterolipid based SMEDDS: A promising tool for cytosolic delivery of antineoplastics
Source:
Elsevier BV
iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy
Source:
Elsevier BV
Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting in vivo.
Source:
Informa UK Limited
Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo.
Source:
Elsevier BV
Specific interaction between galactose branched-cyclodextrins and hepatocytes in vitro
Source:
Elsevier BV
Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
Source:
Elsevier BV
Drug delivery systems using pullulan, a biocompatible polysaccharide produced by fungal fermentation of starch
Source:
Springer Science and Business Media LLC
In Situ Lipidization as a New Approach for the Design of a Self Microemulsifying Drug Delivery System (SMEDDS) of Doxorubicin Hydrochloride for Oral Administration.
Source:
American Scientific Publishers
Galactosylated reduction and pH dual-responsive triblock terpolymer Gal-PEEP-a-PCL-ss-PDMAEMA: a multifunctional carrier for the targeted and simultaneous delivery of doxorubicin and DNA
Source:
Royal Society of Chemistry (RSC)
LYCIUM BARBARUMON DOXORUBICIN CARDIOTOXICITY
Source:
Wiley
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.